Listing 1 - 10 of 26 | << page >> |
Sort by
|
Choose an application
Choose an application
Choose an application
Psychopharmacology --- Psychopharmacology. --- Psychopharmacologie --- Behavioral pharmacology --- Drugs --- Psychotropic effects --- Chemotherapy --- Pharmacology --- Psychotropic drugs
Choose an application
This volume tries to put current therapy - achievements, shortcomings, remaining medical needs - and emerging new targets into the context of increasing knowledge regarding the genetic and neurodevelopmental contributions to the pathophysiology of schizophrenia. Some of the chapters also deal with respective experimental and clinical methodology, biomarkers, and translational aspects of drug development. The volume concentrates on reviewing the ongoing research attempting to identify novel treatments for the cognitive deficits and negative symptoms of schizophrenia, which are not treated adequately by current antipsychotic medications.
Biomedicine. --- Pharmacology/Toxicology. --- Pharmacy. --- Psychopharmacology. --- Biological Psychology. --- Medicine. --- Toxicology. --- Applied psychology. --- Médecine --- Toxicologie --- Pharmacie --- Psychopharmacologie --- Schizophrenia --- Treatment. --- Chemotherapy.
Choose an application
Health Sciences --- Neurology --- Pharmacy and Pharmacology --- Psychiatry & Psychology --- Psychopharmacology --- Neurologie --- Psychopharmacologie --- Periodicals --- Périodiques --- EJMEDEC EJPHARM ELSEVIER-E EPUB-ALPHA-P EPUB-PER-FT MDNEUROL MDPHARMA
Choose an application
615.099 --- 615.099 Poisoning (intoxication). Addiction. Special toxicology --- Poisoning (intoxication). Addiction. Special toxicology --- Psychopharmacology. --- Psychopharmacologie --- Psychiatry --- Pharmacology. Therapy --- Psychotropic drugs --- Mental disorders --- Medical oncology --- Palliative care --- drug therapy --- Mental Disorders --- Medical Oncology. --- drug therapy. --- Psychotropic Drugs. --- Palliative Care. --- Psychopharmacologie. --- Psychotropic Drugs --- Medical Oncology --- Palliative Care
Choose an application
David Healy follows his widely praised study, The Antidepressant Era, with an even more ambitious and dramatic story: the discovery and development of antipsychotic medication. Healy argues that the discovery of chlorpromazine (more generally known as Thorazine) is as significant in the history of medicine as the discovery of penicillin, reminding readers of the worldwide prevalence of insanity within living memory. But Healy tells not of the triumph of science but of a stream of fruitful accidents, of technological discovery leading neuroscientific research, of fierce professional competition and the backlash of the antipsychiatry movement of the 1960s. A chemical treatment was developed for one purpose, and as long as some theoretical rationale could be found, doctors administered it to the insane patients in their care to see if it would help. Sometimes it did, dramatically. Why these treatments worked, Healy argues provocatively, was, and often still is, a mystery. Nonetheless, such discoveries made and unmade academic reputations and inspired intense politicking for the Nobel Prize. Once pharmaceutical companies recognized the commercial potential of antipsychotic medications, financial as well as clinical pressures drove the development of ever more aggressively marketed medications. With verve and immense learning, Healy tells a story with surprising implications in a book that will become the leading scholarly work on its compelling subject.
Psychopharmacology --- Psychotropic drugs --- Psychiatry --- Psychopharmacologie --- Psychotropes --- Psychiatrie --- History. --- Histoire --- Psychiatric drugs --- Psychoactive drugs --- Psychopharmaceuticals --- Behavioral pharmacology --- Drugs --- Psychotropic effects --- Drugs of abuse --- Psychotropic plants --- Chemotherapy --- Pharmacology --- Poets, English --- Keats, John, --- Kēts, Tzōn, --- Kits, Dzhon, --- Kʻichʻŭ, --- キーツ, ジョン
Choose an application
Neuropsychology --- Neurochemistry --- Neurology --- Neurophysiology --- Psychopharmacology --- Neuropsychologie --- Neuroéthologie --- Neuropsychology. --- Psychophysiology --- Neurochemistry. --- Neurology. --- Neurophysiology. --- Psychopharmacology. --- Neurochemistries --- Chemistry --- Neurochimie. --- Neurologie. --- Neurophysiologie. --- Psychopharmacologie. --- Behavioral pharmacology --- Drugs --- Chemotherapy --- Pharmacology --- Psychotropic drugs --- Nervous system --- Neurobiology --- Physiology --- Medicine --- Neuropsychiatry --- Biochemistry --- Neurosciences --- Psychotropic effects --- Diseases
Choose an application
Attention-deficit hyperactivity disorder --- Clinical neuropsychology --- Impulse control disorders --- Neuropsychological tests --- Performance --- Testing --- Adulte --- Enfant --- Psychopharmacologie --- Trouble déficitaire de l'attention avec hyperactivité --- Tests neuropsychologiques. --- Neuropsychologie clinique. --- Neuropsychological tests. --- Clinical neuropsychology.
Choose an application
Stress is one of the most commonly reported precipitants of drug use and is considered the number one cause of relapse to drug abuse. For the past several decades, there have been a number of significant advances in research focusing on the neurobiological and psychosocial aspects of stress and addiction; along with this growth came the recognition of the importance of understanding the interaction of biological and psychosocial factors that influence risk for initiation and maintenance of addictive behaviors. Recent research has started to specifically focus on understanding the nature of how
Drug abuse --- Stress (Psychology) --- Emotional stress --- Mental stress --- Psychological stress --- Tension (Psychology) --- Mental health --- Psychology --- Diathesis-stress model (Psychology) --- Life change events --- Type A behavior --- Drug use --- Substance abuse --- Physiological aspects. --- Psychological aspects. --- Psychobiologie --- Psychopharmacologie --- Pharmacologie --- Stress --- Toxicomanie
Listing 1 - 10 of 26 | << page >> |
Sort by
|